SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Misra A)
 

Search: WFRF:(Misra A) > (2015-2019) > Growth Hormone Rese...

  • Christiansen, J. S. (author)

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • Oxford University Press (OUP),2016

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/238368
  • https://gup.ub.gu.se/publication/238368URI
  • https://doi.org/10.1530/eje-16-0111DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Objective: The Growth Hormone (GH) Research Society (GRS) convened a workshop to address important issues regarding trial design, efficacy, and safety of long-acting growth hormone preparations (LAGH). Participants: A closed meeting of 55 international scientists with expertise in GH, including pediatric and adult endocrinologists, basic scientists, regulatory scientists, and participants from the pharmaceutical industry. Evidence: Current literature was reviewed for gaps in knowledge. Expert opinion was used to suggest studies required to address potential safety and efficacy issues. Consensus process: Following plenary presentations summarizing the literature, breakout groups discussed questions framed by the planning committee. Attendees reconvened after each breakout session to share group reports. A writing team compiled the breakout session reports into a draft document that was discussed and revised in an open forum on the concluding day. This was edited further and then circulated to attendees from academic institutions for review after the meeting. Participants from pharmaceutical companies did not participate in the planning, writing, or in the discussions and text revision on the final day of the workshop. Scientists from industry and regulatory agencies reviewed the manuscript to identify any factual errors. Conclusions: LAGH compounds may represent an advance over daily GH injections because of increased convenience and differing phamacodynamic properties, providing the potential for improved adherence and outcomes. Better methods to assess adherence must be developed and validated. Long-term surveillance registries that include assessment of efficacy, cost-benefit, disease burden, quality of life, and safety are essential for understanding the impact of sustained exposure to LAGH preparations.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Backeljauw, P. F. (author)
  • Bidlingmaier, M. (author)
  • Biller, B. M. K. (author)
  • Boguszewski, M. C. S. (author)
  • Casanueva, F. F. (author)
  • Chanson, P. (author)
  • Chatelain, P. (author)
  • Choong, C. S. (author)
  • Clemmons, D. R. (author)
  • Cohen, L. E. (author)
  • Cohen, P. (author)
  • Frystyk, J. (author)
  • Grimberg, A. (author)
  • Hasegawa, Y. (author)
  • Haymond, M. W. (author)
  • Ho, K. (author)
  • Hoffman, A. R. (author)
  • Holly, J. M. P. (author)
  • Horikawa, R. (author)
  • Hoybye, C. (author)
  • Jorgensen, J. O. L. (author)
  • Johannsson, Gudmundur,1960Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine(Swepub:gu)xjgudn (author)
  • Juul, A. (author)
  • Katznelson, L. (author)
  • Kopchick, J. J. (author)
  • Lee, K. O. (author)
  • Lee, K. W. (author)
  • Luo, X. P. (author)
  • Melmed, S. (author)
  • Miller, B. S. (author)
  • Misra, M. (author)
  • Popovic, V. (author)
  • Rosenfeld, R. G. (author)
  • Ross, J. (author)
  • Ross, R. J. (author)
  • Saenger, P. (author)
  • Strasburger, C. J. (author)
  • Thorner, M. O. (author)
  • Werner, H. (author)
  • Yuen, K. (author)
  • Göteborgs universitetInstitutionen för medicin (creator_code:org_t)

Related titles

  • In:European Journal of Endocrinology: Oxford University Press (OUP)174:60804-46431479-683X

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view